Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

ClinicalTrials.gov ID: NCT00086177

Public ClinicalTrials.gov record NCT00086177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of 8% Progesterone Vaginal Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is being conducted at over 12 pregnancy research centers in the US. The study will compare an investigational treatment with a placebo (a treatment without medication). Neither the investigators nor the patients in the trial will know which treatment has been assigned. All study medications will be given vaginally once a day. Treatment will begin before pregnancy week 23 and will continue until the end of pregnancy week 36.

Study identification

NCT ID
NCT00086177
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Juniper Pharmaceuticals, Inc.
Industry
Enrollment
636 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Jan 2007 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Aug 19, 2010

2004 – 2009

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
42
Facility City State ZIP Site status
University of South Alabama Department of OBGYN Mobile Alabama 36604 —
Visions Clinical Research-Tucson Tucson Arizona 85712 —
Women's Health Department Colton California 92324 —
SanDiego Perinatal Center San Diego California 92123 —
Harbor - UCLA Medical Center Torrance California 90509 —
Kaiser Permanente Denver Colorado 80205 —
Northside Maternal Fetal Specialists Atlanta Georgia 30342 —
Memorial Health University Medical Center Savannah Georgia 31404 —
University of Illinois Chicago Illinois 60612 —
University of Chicago Chicago Illinois 60637 —
Central Baptist Hospital Lexington Kentucky 40503 —
Maternal Fetal Medicine Norton Suburban Hospital Louisville Kentucky 40207 —
Maternal Fetal Medicine &Woman's Health Research Baton Rouge Louisiana 70815 —
Louisiana State University Health Sciences Center-Shreveport Shreveport Louisiana 71103 —
Johns Hopkins Community Physicians Baltimore Maryland 21211 —
Holy Cross Hospital Silver Springs Maryland 20910 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
St. Elizabeth's Medical Center -MFM Brighton Massachusetts 02135 —
St. Louis University St Louis Missouri 63021 —
Washington University St Louis Missouri 63110 —
Cooper University Hospital Camden New Jersey 08103 —
Department of OBGYN, St. Barnabas Medical Center Livingston New Jersey 07039 —
University of New Mexico Albuquerque New Mexico 87131 —
St. Luke's - Roosevelt Hospital New York New York 10019 —
Jacobi Medical Center The Bronx New York 10461 —
Montefiore Medical Center The Bronx New York 10461 —
Pitt County Memorial Hospital Greenville North Carolina 27834 —
Lyndhurst Gynecologic Associates Winston-Salem North Carolina 27103 —
Ohio Permanente Medical Group Bedford Ohio 44146 —
University of Cincinnati Cincinnati Ohio 45219 —
MacDonald Clinical Trials Unit, University Hospitals of Cleveland Cleveland Ohio 44104-5034 —
The Toledo Hospital Toledo Ohio 43606 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Temple University Medical Center Philadelphia Pennsylvania 19140 —
Abington Primary Women's Healthcare Willow Grove Pennsylvania 19090 —
University Medical Group, Dept of OB/GYN Greenville South Carolina 29605 —
Regional Obstetrical Consultants Chattanooga Tennessee 37403 —
Gynecology & Obstetrics Memphis Tennessee 38120 —
Womens Partner In Health Austin Texas 78705 —
Health Central Women's Care Dallas Texas 75231 —
Clinical Research Center of Houston Houston Texas 77054 —
Texas Tech University Health Sciences Center Lubbock Texas 79430 —
Texas Tech Health Sciences Center - Odessa Odessa Texas 79763 —
EVMS Maternal-Fetal Medicine, Hofheimer Hall Norfolk Virginia 23507 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00086177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2010 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00086177 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →